First-in-human study of the safety, pharmacokinetics, and
![](https://ars.els-cdn.com/content/image/1-s2.0-S2589537021000778-gr2.jpg)
![](https://www.researcher-app.com/image/eyJ1cmkiOiJodHRwczovL3MzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL3N0YWNrYWRlbWljL3Byb2R1Y3Rpb24vcGFwZXIvOTQyMzMwNi5wbmciLCJmb3JtYXQiOiJ3ZWJwIiwicXVhbGl0eSI6MTAwLCJub0NhY2hlIjp0cnVlfQ==.webp)
Pharmacokinetics, Safety, and Tolerability of NPC‐21, an Anti‐Cytome
![](https://www.researchgate.net/publication/354024142/figure/fig1/AS:11431281181916378@1692218405276/Study-design-and-dose-escalation-scheme-Eight-participants-were-randomized-to-each_Q320.jpg)
PDF) Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8
![](https://www.mdpi.com/ijms/ijms-22-09507/article_deploy/html/images/ijms-22-09507-g003-550.jpg)
IJMS, Free Full-Text
![](https://www.mdpi.com/ijms/ijms-22-09507/article_deploy/html/images/ijms-22-09507-g001-550.jpg)
IJMS, Free Full-Text
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12079-023-00771-w/MediaObjects/12079_2023_771_Figa_HTML.png)
Role of EGFR and FASN in breast cancer progression
![](https://ars.els-cdn.com/content/image/1-s2.0-S1550413122004478-gr1.jpg)
The role of lipids in cancer progression and metastasis - ScienceDirect
![](https://www.biotrial.com/app/uploads/2023/03/lqvkraz.jpg)
CRO, preclinical services, PK Studies
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12967-018-1710-5/MediaObjects/12967_2018_1710_Fig1_HTML.png)
Reviewing the role of healthy volunteer studies in drug
![](https://www.mdpi.com/biomolecules/biomolecules-13-00944/article_deploy/html/images/biomolecules-13-00944-g001.png)
Biomolecules, Free Full-Text
![](https://www.researchgate.net/publication/372136013/figure/fig3/AS:11431281172596850@1688612004109/Subcutaneous-immunization-with-influenza-and-alum-does-not-elicit-EFRs-a-e-C57BL-6-mice.png)
Subcutaneous immunization with influenza and alum does not elicit
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs13318-023-00847-3/MediaObjects/13318_2023_847_Fig2_HTML.png)
First-in-Human Study of the Safety, Pharmacokinetics, and
![](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-19459-z/MediaObjects/41598_2022_19459_Fig1a_HTML.png)
FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models
![](https://www.frontiersin.org/files/Articles/1195500/fendo-14-1195500-HTML/image_m/fendo-14-1195500-g001.jpg)
Frontiers Metabolic reprogramming of clear cell renal cell carcinoma